Previous Close | 254.05 |
Open | 257.23 |
Bid | 233.50 x 1200 |
Ask | 406.88 x 800 |
Day's Range | 253.27 - 260.49 |
52 Week Range | 235.01 - 405.90 |
Volume | |
Avg. Volume | 418,975 |
Market Cap | 11.893B |
Beta (5Y Monthly) | 1.16 |
PE Ratio (TTM) | 27.76 |
EPS (TTM) | 9.14 |
Earnings Date | Apr 27, 2022 - May 02, 2022 |
Forward Dividend & Yield | 1.36 (0.57%) |
Ex-Dividend Date | Aug 12, 2022 |
1y Target Est | 315.18 |
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
For UroLift, Teleflex (TFX) witnesses revenue declines in all sites of service, including hospital, ASC and physician's office.
WAYNE, Pa., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has been awarded a contract for the supply of Central Venous Access products from Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company. The agreement is effective starting August 1, 2022. Vizient provides solutions and services that improve the delivery of high-value care by aligning cost, quality, and market performance for m